首页 > 最新文献

Rozhledy v Chirurgii最新文献

英文 中文
Pancreatic cancer - systemic treatment.
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.33699/PIS.2024.103.4.110-116
M Liberko

Pancreatic cancer is a disease with the worst long-term survival across all stages. In clinical practice, due to asymptomatic or non-specific signs and symptoms we diagnose patients mainly with locally advanced and metastatic disease, where median survival is approximately one year. However, cases of an early local recurrence or distant metastases are observed even in early stages after curative surgery, and long-term survival is an exception even in these early stages of the disease. Despite these adverse characteristics, an improvement in median overall survival has been observed also in patients with pancreatic cancer, particularly in the last few years. It is due to advancements in the diagnosis, surgery, but mainly due to improvements in cancer treatment (chemotherapy - adjuvant, neoadjuvant, perioperative, induction and palliative, and radiotherapy). The results of many studies across all stages (resectable, borderline resectable, locally advanced, metastatic) have been published, showing an improved survival. The aim of this article is to provide a review of current treatment options for pancreatic ductal adenocarcinoma.

胰腺癌是所有阶段中长期生存率最差的疾病。在临床实践中,由于无症状或无特异性体征和症状,我们主要将患者诊断为局部晚期和转移性疾病,中位生存期约为一年。然而,即使在治愈性手术后的早期阶段,也会出现早期局部复发或远处转移的病例,即使在这些疾病的早期阶段,长期生存也是例外。尽管存在这些不利特点,但胰腺癌患者的中位总生存期也有所改善,尤其是在最近几年。这归功于诊断和手术方面的进步,但主要是由于癌症治疗(化疗--辅助治疗、新辅助治疗、围手术期治疗、诱导治疗和姑息治疗以及放疗)的改进。许多针对各期癌症(可切除、边缘可切除、局部晚期、转移性)的研究结果已经公布,显示生存率有所提高。本文旨在回顾胰腺导管腺癌的现有治疗方案。
{"title":"Pancreatic cancer - systemic treatment.","authors":"M Liberko","doi":"10.33699/PIS.2024.103.4.110-116","DOIUrl":"https://doi.org/10.33699/PIS.2024.103.4.110-116","url":null,"abstract":"<p><p>Pancreatic cancer is a disease with the worst long-term survival across all stages. In clinical practice, due to asymptomatic or non-specific signs and symptoms we diagnose patients mainly with locally advanced and metastatic disease, where median survival is approximately one year. However, cases of an early local recurrence or distant metastases are observed even in early stages after curative surgery, and long-term survival is an exception even in these early stages of the disease. Despite these adverse characteristics, an improvement in median overall survival has been observed also in patients with pancreatic cancer, particularly in the last few years. It is due to advancements in the diagnosis, surgery, but mainly due to improvements in cancer treatment (chemotherapy - adjuvant, neoadjuvant, perioperative, induction and palliative, and radiotherapy). The results of many studies across all stages (resectable, borderline resectable, locally advanced, metastatic) have been published, showing an improved survival. The aim of this article is to provide a review of current treatment options for pancreatic ductal adenocarcinoma.</p>","PeriodicalId":52413,"journal":{"name":"Rozhledy v Chirurgii","volume":"103 4","pages":"110-116"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143383943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The utilization of 3D printing in surgery as an innovative approach to preoperative planning. 在外科手术中利用 3D 打印技术作为术前规划的创新方法。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.48095/ccrvch2024305
J Hrubovčák, L Tulinský, M Pieš, R Hájovský, J Velička, K Chrz, T Bosek, J Szeliga, L Martínek

Introduction: 3D printing, a concept over 40 years old, is finding broader application in clinical practice thanks to technological advancements. At University Hospital Ostrava, 3D printing is utilized to create anatomically accurate models of specific patients before surgical procedures based on imaging data.

Case series: 3D printing is employed as a complement to conventional imaging methods to produce morphologically precise models of anatomical structures of individual patients. These models primarily serve for preoperative planning in elective abdominal, vascular, and thoracic surgery. They are also used in planning osteosynthesis of complex fractures and corrective osteotomies. Multicolor printing, although increasing the process's time demands, allows better clarity and differentiation of individual anatomical structures within a single model.

Discussion: Compared to 2D images, 3D models provide better spatial orientation and awareness of the operated structures, contributing to improved surgical outcomes. The benefits of 3D printing in preoperative planning and patient education are confirmed by studies across the fields ranging from cardiac surgery to traumatology.

Conclusion: After overcoming initial challenges, 3D printing has become a reliable component of the surgical arsenal at University Hospital Ostrava for elective surgery. While 3D printing does not represent a universal answer to all medical challenges, its role is highly beneficial and promising in many indicated cases.

导言:3D 打印是一个已有 40 多年历史的概念,随着技术的进步,它在临床实践中的应用越来越广泛。在俄斯特拉发大学医院,3D 打印技术被用于在手术前根据成像数据为特定患者制作解剖学上精确的模型:作为传统成像方法的补充,3D 打印技术被用于制作个体患者解剖结构的形态精确模型。这些模型主要用于选择性腹部、血管和胸部手术的术前规划。它们还用于规划复杂骨折的骨合成和矫正截骨手术。多色打印虽然增加了整个过程的时间要求,但能使单个模型中的各个解剖结构更加清晰和分明:讨论:与二维图像相比,三维模型提供了更好的空间定位和对手术结构的认识,有助于改善手术效果。从心脏外科到创伤学等各个领域的研究都证实了三维打印在术前规划和患者教育方面的优势:在克服了最初的挑战后,3D 打印技术已成为俄斯特拉发大学医院外科武器库中用于择期手术的可靠组成部分。虽然 3D 打印技术并不能解决所有的医疗难题,但它在许多病例中的作用是非常有益和有前景的。
{"title":"The utilization of 3D printing in surgery as an innovative approach to preoperative planning.","authors":"J Hrubovčák, L Tulinský, M Pieš, R Hájovský, J Velička, K Chrz, T Bosek, J Szeliga, L Martínek","doi":"10.48095/ccrvch2024305","DOIUrl":"10.48095/ccrvch2024305","url":null,"abstract":"<p><strong>Introduction: </strong>3D printing, a concept over 40 years old, is finding broader application in clinical practice thanks to technological advancements. At University Hospital Ostrava, 3D printing is utilized to create anatomically accurate models of specific patients before surgical procedures based on imaging data.</p><p><strong>Case series: </strong>3D printing is employed as a complement to conventional imaging methods to produce morphologically precise models of anatomical structures of individual patients. These models primarily serve for preoperative planning in elective abdominal, vascular, and thoracic surgery. They are also used in planning osteosynthesis of complex fractures and corrective osteotomies. Multicolor printing, although increasing the process's time demands, allows better clarity and differentiation of individual anatomical structures within a single model.</p><p><strong>Discussion: </strong>Compared to 2D images, 3D models provide better spatial orientation and awareness of the operated structures, contributing to improved surgical outcomes. The benefits of 3D printing in preoperative planning and patient education are confirmed by studies across the fields ranging from cardiac surgery to traumatology.</p><p><strong>Conclusion: </strong>After overcoming initial challenges, 3D printing has become a reliable component of the surgical arsenal at University Hospital Ostrava for elective surgery. While 3D printing does not represent a universal answer to all medical challenges, its role is highly beneficial and promising in many indicated cases.</p>","PeriodicalId":52413,"journal":{"name":"Rozhledy v Chirurgii","volume":"103 8","pages":"305-312"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142309120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Malignant melanoma metastasis as a rare cause of abdominal pain. 恶性黑色素瘤转移是腹痛的罕见病因。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.48095/ccrvch2024313
T Kriegler, T Dušek, V Ninger, P Hanousek, M Podhola

The authors present the case of a 71-year-old female patient who was operated on for 16 days of abdominal pain. The work points to malignant melanoma as a rare cause of abdominal pain and then shows the inscrutability of malignant melanoma and the importance of a multidisciplinary approach to this type of disease including subsequent dispensary by an oncologist. The emphasis on the prevention of this disease is an integral part of this approach.

作者介绍了一例因腹痛 16 天而接受手术的 71 岁女性患者的病例。作品指出恶性黑色素瘤是腹痛的罕见病因,然后说明了恶性黑色素瘤的不可预测性,以及采用多学科方法(包括肿瘤专家的后续诊疗)治疗这类疾病的重要性。强调这种疾病的预防是这种方法不可分割的一部分。
{"title":"Malignant melanoma metastasis as a rare cause of abdominal pain.","authors":"T Kriegler, T Dušek, V Ninger, P Hanousek, M Podhola","doi":"10.48095/ccrvch2024313","DOIUrl":"10.48095/ccrvch2024313","url":null,"abstract":"<p><p>The authors present the case of a 71-year-old female patient who was operated on for 16 days of abdominal pain. The work points to malignant melanoma as a rare cause of abdominal pain and then shows the inscrutability of malignant melanoma and the importance of a multidisciplinary approach to this type of disease including subsequent dispensary by an oncologist. The emphasis on the prevention of this disease is an integral part of this approach.</p>","PeriodicalId":52413,"journal":{"name":"Rozhledy v Chirurgii","volume":"103 8","pages":"313-317"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142309118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Our experience with robotic-assisted thymic surgery. 我们在机器人辅助胸腺手术方面的经验。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.33699/PIS.2024.103.2.40-47
M Podhráský, J Tvrdoň, J Schützner

Thoracic surgery is increasingly influenced by the development of minimally invasive approaches which have also influenced surgery in the area of the anterior mediastinum. The previously standard approach to the thymus via partial sternotomy was gradually replaced by the videothoracoscopic approach in most cases. In recent years, robotically assisted surgery has been gaining ground worldwide in this area, as well. The aim of our paper is to provide a comprehensive overview of procedures in the field of the thymus, including their indications, and to share our first experience with robot-assisted thymus surgery. At the 3rd Department of Surgery, since the start of the robot-assisted thymus surgery program, 23 thymectomies have been performed using this approach, of which 17 were performed for thymoma, 3 for myasthenia gravis, and 3 for parathyroid adenoma localized in thymus tissue. From our experience and the available data, it follows that the length of hospitalization, the rate of complications and the resulting effect of robot-assisted procedures is comparable to VTS procedures; however, the robot-assisted surgery also allows for mini-invasive treatment even in significantly obese patients and in patients with advanced thymic tumors who would otherwise be indicated for open thymectomy.

微创方法的发展对胸外科的影响越来越大,这也影响了前纵隔区域的手术。在大多数情况下,以前通过胸骨部分切开术进入胸腺的标准方法逐渐被视频胸腔镜方法所取代。近年来,机器人辅助手术在这一领域也在全球范围内逐渐兴起。本文旨在全面概述胸腺领域的手术,包括其适应症,并分享我们首次使用机器人辅助胸腺手术的经验。在外科第三部,自机器人辅助胸腺手术项目启动以来,已经使用这种方法进行了23例胸腺切除手术,其中17例是胸腺瘤手术,3例是重症肌无力手术,3例是胸腺组织局部甲状旁腺腺瘤手术。从我们的经验和现有数据来看,机器人辅助手术的住院时间、并发症发生率和效果与VTS手术不相上下;不过,机器人辅助手术还允许对明显肥胖的患者和患有晚期胸腺肿瘤的患者进行微创治疗,否则这些患者将需要进行开放式胸腺切除术。
{"title":"Our experience with robotic-assisted thymic surgery.","authors":"M Podhráský, J Tvrdoň, J Schützner","doi":"10.33699/PIS.2024.103.2.40-47","DOIUrl":"https://doi.org/10.33699/PIS.2024.103.2.40-47","url":null,"abstract":"<p><p>Thoracic surgery is increasingly influenced by the development of minimally invasive approaches which have also influenced surgery in the area of the anterior mediastinum. The previously standard approach to the thymus via partial sternotomy was gradually replaced by the videothoracoscopic approach in most cases. In recent years, robotically assisted surgery has been gaining ground worldwide in this area, as well. The aim of our paper is to provide a comprehensive overview of procedures in the field of the thymus, including their indications, and to share our first experience with robot-assisted thymus surgery. At the 3rd Department of Surgery, since the start of the robot-assisted thymus surgery program, 23 thymectomies have been performed using this approach, of which 17 were performed for thymoma, 3 for myasthenia gravis, and 3 for parathyroid adenoma localized in thymus tissue. From our experience and the available data, it follows that the length of hospitalization, the rate of complications and the resulting effect of robot-assisted procedures is comparable to VTS procedures; however, the robot-assisted surgery also allows for mini-invasive treatment even in significantly obese patients and in patients with advanced thymic tumors who would otherwise be indicated for open thymectomy.</p>","PeriodicalId":52413,"journal":{"name":"Rozhledy v Chirurgii","volume":"103 2","pages":"40-47"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140865877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Breast cancer in 80+ year olds. 80 岁以上老人患乳腺癌。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.48095/ccrvch2024258
P Kosáč, M Zábojníková, P Vážan, V Petrů, M Ratajský, K Lajmar, B Dudešek, P Kudlová, J Duben, L Podrazká, J Gatěk

Introduction: The risk of breast cancer increases with increasing age. The aim of our retrospective study was to determine the extent of breast and axillary surgery, including subsequent adjuvant therapy, in 80-year and older patients.

Methods: Between 2017 and 2021, 834 breast cancer patients were operated in the Surgical Department of the EUC Clinic. Ninety-eight women (2× with bilateral cancer) and 2 men were included in this retrospective study. A total of 102 breast cancer cases in patients older than 80 years were analyzed. The surgical procedure corresponded to the stage of the disease and the general condition of the patient. Adjuvant systemic therapy was indicated according to the same principles.

Results: At the time of surgery, the patients were more than 80 years old (80-96 years). The predominant type of invasive ductal carcinoma was diagnosed 83×, lobular carcinoma 6×, mucinous 6×, papillary carcinoma 4×, other 3×, with luminal A, B predominating (89×). The breast-conserving procedures were performed 63×. Sentinel node biopsy was performed 65×, supplemented by axillary lymph node dissection 13×. Primary axillary lymph node dissection was performed 15×. No axillary procedure was performed 23×. Radiotherapy was given 49×, chemotherapy 9× and hormonal therapy 82×. Local and regional recurrences were each observed 2×. A total of 37 patients died, 10 of them from breast cancer.

Conclusion: The most common cause of death in patients aged 80+ years is a cardiovascular disease, not breast cancer itself. This fact should be taken into account when determining the treatment plan.

导言患乳腺癌的风险随着年龄的增长而增加。我们的回顾性研究旨在确定80岁及以上患者的乳腺和腋窝手术范围,包括后续的辅助治疗:2017年至2021年期间,EUC诊所外科共为834名乳腺癌患者进行了手术。这项回顾性研究共纳入98名女性(2人患有双侧癌症)和2名男性。共分析了 102 例 80 岁以上的乳腺癌患者。手术方法与疾病的分期和患者的一般情况相符。辅助系统治疗也是根据同样的原则进行的:手术时,患者年龄均超过 80 岁(80-96 岁)。浸润性导管癌的主要类型为 83×,小叶癌 6×,粘液癌 6×,乳头状癌 4×,其他 3×,以管腔 A、B 型为主(89×)。保乳手术 63 例。前哨活检 65 例,辅以腋窝淋巴结清扫 13 例。主要腋窝淋巴结清扫术 15×。未进行腋窝手术 23×。放疗 49 次,化疗 9 次,激素治疗 82 次。观察到局部和区域复发各 2 次。共有 37 名患者死亡,其中 10 人死于乳腺癌:结论:80 岁以上患者最常见的死因是心血管疾病,而不是乳腺癌本身。在确定治疗方案时应考虑到这一事实。
{"title":"Breast cancer in 80+ year olds.","authors":"P Kosáč, M Zábojníková, P Vážan, V Petrů, M Ratajský, K Lajmar, B Dudešek, P Kudlová, J Duben, L Podrazká, J Gatěk","doi":"10.48095/ccrvch2024258","DOIUrl":"https://doi.org/10.48095/ccrvch2024258","url":null,"abstract":"<p><strong>Introduction: </strong>The risk of breast cancer increases with increasing age. The aim of our retrospective study was to determine the extent of breast and axillary surgery, including subsequent adjuvant therapy, in 80-year and older patients.</p><p><strong>Methods: </strong>Between 2017 and 2021, 834 breast cancer patients were operated in the Surgical Department of the EUC Clinic. Ninety-eight women (2× with bilateral cancer) and 2 men were included in this retrospective study. A total of 102 breast cancer cases in patients older than 80 years were analyzed. The surgical procedure corresponded to the stage of the disease and the general condition of the patient. Adjuvant systemic therapy was indicated according to the same principles.</p><p><strong>Results: </strong>At the time of surgery, the patients were more than 80 years old (80-96 years). The predominant type of invasive ductal carcinoma was diagnosed 83×, lobular carcinoma 6×, mucinous 6×, papillary carcinoma 4×, other 3×, with luminal A, B predominating (89×). The breast-conserving procedures were performed 63×. Sentinel node biopsy was performed 65×, supplemented by axillary lymph node dissection 13×. Primary axillary lymph node dissection was performed 15×. No axillary procedure was performed 23×. Radiotherapy was given 49×, chemotherapy 9× and hormonal therapy 82×. Local and regional recurrences were each observed 2×. A total of 37 patients died, 10 of them from breast cancer.</p><p><strong>Conclusion: </strong>The most common cause of death in patients aged 80+ years is a cardiovascular disease, not breast cancer itself. This fact should be taken into account when determining the treatment plan.</p>","PeriodicalId":52413,"journal":{"name":"Rozhledy v Chirurgii","volume":"103 7","pages":"258-262"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of neoadjuvant treatment in localized pancreatic cancer. 新辅助治疗在局部胰腺癌中的作用。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.48095/ccrvch2024429
R Němeček, M Eid

Pancreatic carcinoma is a prognostically unfavorable cancer disease with growing incidence and mortality, which is the 3rd most common cause of cancer-related death in developed countries. The 5-year survival rate does not exceed 11% and is the lowest across all cancer diagnoses. Only about 20-30% of patients have resectable (RPC) or borderline resectable (BRPC) disease at the time of diagnosis. Radical resection is an essential therapeutic modality in these cases and is considered the only potentially curative procedure. Neoadjuvant chemotherapy and/or chemoradiotherapy is established mainly in BRPC. The role of neoadjuvant therapy in RPC is currently under investigation. This review article describes the current options, advantages and disadvantages of neoadjuvant treatment in BRPC and RPC.

胰腺癌是一种发病率和死亡率不断上升的预后不利的癌症疾病,是发达国家癌症相关死亡的第三大常见原因。5年生存率不超过11%,是所有癌症诊断中最低的。只有约20-30%的患者在诊断时患有可切除(RPC)或边缘性可切除(BRPC)疾病。根治性切除是这些病例的基本治疗方式,被认为是唯一可能治愈的方法。新辅助化疗和/或放化疗主要用于BRPC。新辅助治疗在RPC中的作用目前正在研究中。本文综述了目前BRPC和RPC的新辅助治疗方案及其优缺点。
{"title":"The role of neoadjuvant treatment in localized pancreatic cancer.","authors":"R Němeček, M Eid","doi":"10.48095/ccrvch2024429","DOIUrl":"https://doi.org/10.48095/ccrvch2024429","url":null,"abstract":"<p><p>Pancreatic carcinoma is a prognostically unfavorable cancer disease with growing incidence and mortality, which is the 3rd most common cause of cancer-related death in developed countries. The 5-year survival rate does not exceed 11% and is the lowest across all cancer diagnoses. Only about 20-30% of patients have resectable (RPC) or borderline resectable (BRPC) disease at the time of diagnosis. Radical resection is an essential therapeutic modality in these cases and is considered the only potentially curative procedure. Neoadjuvant chemotherapy and/or chemoradiotherapy is established mainly in BRPC. The role of neoadjuvant therapy in RPC is currently under investigation. This review article describes the current options, advantages and disadvantages of neoadjuvant treatment in BRPC and RPC.</p>","PeriodicalId":52413,"journal":{"name":"Rozhledy v Chirurgii","volume":"103 11","pages":"429-436"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142792774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fractures of the posterior malleolus as a part of complex ankle fractures: Trends in diagnosis and treatment at our institution.
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.33699/PIS.2024.103.5.175-180
V Kunc, L Kopp

Introduction: The management of posterior malleolus fractures has experienced notable advancements in recent years, predominantly driven by the CT-based Bartoníček-Rammelt classification. This study aims to systematically document the evolving trends in the approach to these fractures within the context of our institution.

Methods: A comprehensive retrospective analysis was undertaken involving 66 patients who underwent surgical intervention for posterior malleolus fractures at our institution during the years 2020 and 2021. Patient classification was conducted based on the Lauge-Hansen classification, with additional categorization according to the Bartoníček-Rammelt classification in instances where CT scans were performed.

Results: CT examinations were performed in 30 patients (45.45%); according to the Bartoníček-Rammelt classification they revealed type I in 2 cases, type II in 7 cases, type III in 12 cases, and type IV in 9 cases. Patients lacking specific fixation for type III posterior malleolus fractures, as per the Bartoníček-Rammelt classification, exhibited the most unfavorable treatment outcomes.

Conclusion: Our findings elucidate a progressive trend in the utilization of CT examinations between 2020 and 2021, although this escalation remained insufficient during this period. Consequently, we have intensified efforts to advocate for increased use of CT scans. The issues with not optimally treated type III fractures, as classified by Bartoníček-Rammelt, are quite clear from our study. We were surprised by how often these cases occurred, and they often led to more complications. These fractures diagnosed by CT scans were not treated optimally, as surgeons tend to be reluctant in adopting modern treatment procedures. This emphasizes the importance of ongoing and thorough education in all kinds of healthcare settings, including those that specialize in ankle and foot surgery.

{"title":"Fractures of the posterior malleolus as a part of complex ankle fractures: Trends in diagnosis and treatment at our institution.","authors":"V Kunc, L Kopp","doi":"10.33699/PIS.2024.103.5.175-180","DOIUrl":"https://doi.org/10.33699/PIS.2024.103.5.175-180","url":null,"abstract":"<p><strong>Introduction: </strong>The management of posterior malleolus fractures has experienced notable advancements in recent years, predominantly driven by the CT-based Bartoníček-Rammelt classification. This study aims to systematically document the evolving trends in the approach to these fractures within the context of our institution.</p><p><strong>Methods: </strong>A comprehensive retrospective analysis was undertaken involving 66 patients who underwent surgical intervention for posterior malleolus fractures at our institution during the years 2020 and 2021. Patient classification was conducted based on the Lauge-Hansen classification, with additional categorization according to the Bartoníček-Rammelt classification in instances where CT scans were performed.</p><p><strong>Results: </strong>CT examinations were performed in 30 patients (45.45%); according to the Bartoníček-Rammelt classification they revealed type I in 2 cases, type II in 7 cases, type III in 12 cases, and type IV in 9 cases. Patients lacking specific fixation for type III posterior malleolus fractures, as per the Bartoníček-Rammelt classification, exhibited the most unfavorable treatment outcomes.</p><p><strong>Conclusion: </strong>Our findings elucidate a progressive trend in the utilization of CT examinations between 2020 and 2021, although this escalation remained insufficient during this period. Consequently, we have intensified efforts to advocate for increased use of CT scans. The issues with not optimally treated type III fractures, as classified by Bartoníček-Rammelt, are quite clear from our study. We were surprised by how often these cases occurred, and they often led to more complications. These fractures diagnosed by CT scans were not treated optimally, as surgeons tend to be reluctant in adopting modern treatment procedures. This emphasizes the importance of ongoing and thorough education in all kinds of healthcare settings, including those that specialize in ankle and foot surgery.</p>","PeriodicalId":52413,"journal":{"name":"Rozhledy v Chirurgii","volume":"103 5","pages":"175-180"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143400639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intraosseous ganglion cyst of the scaphoid with an extraosseous component -an uncommon cause of volar wrist pain: case report and literature review.
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.33699/PIS.2024.103.5.193-198
D Ira, B Čechová, M Krtička, J Kovařík

Intraosseous ganglion is a relatively rare cause of chronic wrist pain. The ganglion is most commonly found in the os lunatum and os scaphoideum and in many cases includes an extraosseous component, both of which can be a source of clinical difficulty. In our case report, we present a patient with atypical chronic volar wrist pain who was diagnosed to have an intraosseous ganglion of the os scaphoideum with a volar extraosseous component as the main source of her problems. The patient had both components of the ganglion removed and the defect in the os scaphoideum was filled with an autogenous cancellous bone graft resulting in resolution of the clinical complaints and elimination of the risk of os scaphoideum fracture. The diagnostic and therapeutic considerations in patients found to have an intraosseous ganglion of the wrist with an extraosseous component are described and discussed in relation to the relevant literature.

{"title":"Intraosseous ganglion cyst of the scaphoid with an extraosseous component -an uncommon cause of volar wrist pain: case report and literature review.","authors":"D Ira, B Čechová, M Krtička, J Kovařík","doi":"10.33699/PIS.2024.103.5.193-198","DOIUrl":"https://doi.org/10.33699/PIS.2024.103.5.193-198","url":null,"abstract":"<p><p>Intraosseous ganglion is a relatively rare cause of chronic wrist pain. The ganglion is most commonly found in the os lunatum and os scaphoideum and in many cases includes an extraosseous component, both of which can be a source of clinical difficulty. In our case report, we present a patient with atypical chronic volar wrist pain who was diagnosed to have an intraosseous ganglion of the os scaphoideum with a volar extraosseous component as the main source of her problems. The patient had both components of the ganglion removed and the defect in the os scaphoideum was filled with an autogenous cancellous bone graft resulting in resolution of the clinical complaints and elimination of the risk of os scaphoideum fracture. The diagnostic and therapeutic considerations in patients found to have an intraosseous ganglion of the wrist with an extraosseous component are described and discussed in relation to the relevant literature.</p>","PeriodicalId":52413,"journal":{"name":"Rozhledy v Chirurgii","volume":"103 5","pages":"193-198"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143400644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Breast cancer localization by iodine seed 125I vs. wire- -guided localization - retrospective case-control study. 通过碘粒子 125I 与导线引导定位法进行乳腺癌定位--回顾性病例对照研究。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.48095/ccrvch2024263
J Žatecký, Z Heralt, D Sekret, E Sehnálková, M Peteja

Introduction: For many years, the gold standard in the localization of non-palpable malignant breast tumors has been the use of wire-guided method. However, this has recently been replaced by more modern localization techniques in many institutions.

Methods: This is a retrospective case-control study comparing two localization techniques (iodine seed 125I and wire-guided localization) for localizing non-palpable tumors in patients with histologically verified breast carcinoma.

Results: The study included 62 patients - 31 with localization of malignant breast tumor by iodine seed (subgroup 125I) and 31 by wire-guided localization (subgroup FV). The average volume of the resected tissue in subgroup 125I (46.2 cm3) was statistically significantly smaller compared to subgroup FV (83.7 cm3; P = 0.0063). R0 resection was achieved in 29 cases (93.5%) in subgroup 125I and in 24 cases (77.4%) in subgroup FV (P = 0.0714). In subgroup 125I, re-resection was not indicated in any case, while in subgroup FV, re-resection due to tumor reaching the margin was indicated in 6 cases (19.4%; P = 0.01).

Conclusion: Our initial experience show that the use of iodine seeds for localizing non-palpable breast tumors is associated with the removal of a smaller volume of resected tissue compared to wire-guided localization, with a trend towards more frequent achievement of R0 resection. In the subgroup of patients localized with iodine seeds, there was a smaller proportion of re-resections due to inadequate safety margins.

导言:多年来,非扪及恶性乳腺肿瘤定位的金标准一直是使用线导法。然而,最近在许多机构中,这种方法已被更现代化的定位技术所取代:这是一项回顾性病例对照研究,比较了两种定位技术(碘粒子 125I 和导丝定位)对组织学确诊的乳腺癌患者的非扪及肿瘤的定位效果:该研究包括 62 名患者,其中 31 名通过碘粒子定位(125I 亚组),31 名通过导线定位(FV 亚组)。与 FV 亚组(83.7 cm3;P = 0.0063)相比,125I 亚组切除组织的平均体积(46.2 cm3)明显小于 FV 亚组(83.7 cm3;P = 0.0063)。125I 亚组有 29 例(93.5%)实现了 R0 切除,FV 亚组有 24 例(77.4%)实现了 R0 切除(P = 0.0714)。在 125I 亚组中,没有任何病例需要再次切除,而在 FV 亚组中,有 6 例病例(19.4%;P = 0.01)因肿瘤到达边缘而需要再次切除:我们的初步经验表明,使用碘粒子定位非扪及乳腺肿瘤与线引导定位相比,切除组织的体积更小,而且有更多实现 R0 切除的趋势。在使用碘粒子定位的患者分组中,因安全边缘不足而再次切除的比例较小。
{"title":"Breast cancer localization by iodine seed 125I vs. wire- -guided localization - retrospective case-control study.","authors":"J Žatecký, Z Heralt, D Sekret, E Sehnálková, M Peteja","doi":"10.48095/ccrvch2024263","DOIUrl":"https://doi.org/10.48095/ccrvch2024263","url":null,"abstract":"<p><strong>Introduction: </strong>For many years, the gold standard in the localization of non-palpable malignant breast tumors has been the use of wire-guided method. However, this has recently been replaced by more modern localization techniques in many institutions.</p><p><strong>Methods: </strong>This is a retrospective case-control study comparing two localization techniques (iodine seed 125I and wire-guided localization) for localizing non-palpable tumors in patients with histologically verified breast carcinoma.</p><p><strong>Results: </strong>The study included 62 patients - 31 with localization of malignant breast tumor by iodine seed (subgroup 125I) and 31 by wire-guided localization (subgroup FV). The average volume of the resected tissue in subgroup 125I (46.2 cm3) was statistically significantly smaller compared to subgroup FV (83.7 cm3; P = 0.0063). R0 resection was achieved in 29 cases (93.5%) in subgroup 125I and in 24 cases (77.4%) in subgroup FV (P = 0.0714). In subgroup 125I, re-resection was not indicated in any case, while in subgroup FV, re-resection due to tumor reaching the margin was indicated in 6 cases (19.4%; P = 0.01).</p><p><strong>Conclusion: </strong>Our initial experience show that the use of iodine seeds for localizing non-palpable breast tumors is associated with the removal of a smaller volume of resected tissue compared to wire-guided localization, with a trend towards more frequent achievement of R0 resection. In the subgroup of patients localized with iodine seeds, there was a smaller proportion of re-resections due to inadequate safety margins.</p>","PeriodicalId":52413,"journal":{"name":"Rozhledy v Chirurgii","volume":"103 7","pages":"263-268"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prophylactic surgical mesh placement as a prevention of parastomal hernia in open radical cystectomy with ileal conduit diversion - pilot study. 在开腹根治性膀胱切除术和回肠导管改道术中,预防性手术网片置入可预防吻合口旁疝--试点研究。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.33699/PIS.2024.103.3.91-95
M Louda, P Navrátil, Š Šachová, L Holub, A Fibír, M Balík, M Broďák

Introduction: This study examines the efficacy of prophylactic mesh implantation during open radical cystectomy with ileal conduit diversion in preventing parastomal hernias (PH). Despite PH being a common complication, prophylactic methods have been underexplored.

Methods: A pilot, single-center, prospective cohort study was conducted involving five patients undergoing surgery with mesh implantation. Demographic and clinical characteristics were monitored, including the incidence of PH, operation time, blood loss, and hospitalization duration.

Results: During the mean follow-up period of 9.1±3.2 months post-operation, no occurrences of PH were observed in the patient group. Despite the risks associated with implanting foreign material in an area of surgery involving open small intestine, no infectious complications were noted.

Conclusion: Prophylactic mesh implantation in radical cystectomy with ileal conduit diversion appears to be an effective preventive measure against PH. Further extensive studies are required to definitively confirm the efficacy and safety of mesh use in this context.

简介本研究探讨了在开腹根治性膀胱切除术和回肠导管改道术中植入预防性网片对预防吻合口旁疝气(PH)的效果。尽管PH是一种常见的并发症,但预防性方法一直未得到充分探索:方法:进行了一项试验性、单中心、前瞻性队列研究,涉及五名接受网片植入手术的患者。结果:在平均 9.9 个月的随访期间,有 5 名患者接受了网片植入手术,并监测了人口统计学和临床特征,包括 PH 的发生率、手术时间、失血量和住院时间:结果:在手术后平均 9.1±3.2 个月的随访期间,患者组未观察到 PH 的发生。尽管在开放性小肠手术区域植入异物存在风险,但未发现感染性并发症:结论:在根治性膀胱切除术和回肠导管改道术中植入预防性网片似乎是预防 PH 的有效措施。结论:在根治性膀胱切除术和回肠导管改道术中植入预防性网片似乎是一种有效的 PH 预防措施,但还需要进一步的广泛研究来明确证实在这种情况下使用网片的有效性和安全性。
{"title":"Prophylactic surgical mesh placement as a prevention of parastomal hernia in open radical cystectomy with ileal conduit diversion - pilot study.","authors":"M Louda, P Navrátil, Š Šachová, L Holub, A Fibír, M Balík, M Broďák","doi":"10.33699/PIS.2024.103.3.91-95","DOIUrl":"https://doi.org/10.33699/PIS.2024.103.3.91-95","url":null,"abstract":"<p><strong>Introduction: </strong>This study examines the efficacy of prophylactic mesh implantation during open radical cystectomy with ileal conduit diversion in preventing parastomal hernias (PH). Despite PH being a common complication, prophylactic methods have been underexplored.</p><p><strong>Methods: </strong>A pilot, single-center, prospective cohort study was conducted involving five patients undergoing surgery with mesh implantation. Demographic and clinical characteristics were monitored, including the incidence of PH, operation time, blood loss, and hospitalization duration.</p><p><strong>Results: </strong>During the mean follow-up period of 9.1±3.2 months post-operation, no occurrences of PH were observed in the patient group. Despite the risks associated with implanting foreign material in an area of surgery involving open small intestine, no infectious complications were noted.</p><p><strong>Conclusion: </strong>Prophylactic mesh implantation in radical cystectomy with ileal conduit diversion appears to be an effective preventive measure against PH. Further extensive studies are required to definitively confirm the efficacy and safety of mesh use in this context.</p>","PeriodicalId":52413,"journal":{"name":"Rozhledy v Chirurgii","volume":"103 3","pages":"91-95"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141421860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Rozhledy v Chirurgii
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1